Jinnouchi, Hiroyuki
Sakakura, Kenichi
Taniguchi, Yousuke
Tsukui, Takunori
Watanabe, Yusuke
Yamamoto, Kei
Seguchi, Masaru
Wada, Hiroshi
Fujita, Hideo
Article History
Received: 13 October 2021
Accepted: 25 March 2022
First Online: 5 April 2022
Competing interests
: Dr. Jinnouchi has received speaking honoraria from Abbott Vascular and Terumo. Dr. Sakakura has received speaking honoraria from Abbott Vascular, Boston Scientific, Medtronic Cardiovascular, Terumo, OrbusNeich, Japan Lifeline, Kaneka, and NIPRO; he has served as a proctor for Rotablator for Boston Scientific, and he has served as a consultant for Abbott Vascular and Boston Scientific. Prof. Fujita has served as a consultant for Mehergen Group Holdings, Inc. The rest of the authors have no conflict of interest.